BBVA USA’s Vivani Medical VANI Stock Holding History

BBVA USA’s Portfolio VANI Stock Details VANI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-1,508	Closed	-$22K	–	1027
2021 Q2	$22K	Buy	+1,508	New	+$29.1K	﹤0.01%	795

Other funds holding VANI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

SFI

Susquehanna Fundamental Investments Bala Cynwyd, Pennsylvania $2.67B AUM 21.74% 1-Year Est. Return

Paloma Partners Greenwich, Connecticut $510M AUM 286.05% 1-Year Est. Return

BBVA USA's VANI Position: Q3 2021 in Review

BBVA USA sold out of Vivani Medical (VANI) in Q3 2021, closing a stake of 1,508 shares — an estimated $22K sold.

BBVA USA first reported a position in VANI in Q2 2021 and held it in 1 quarter. The position peaked at $22K in Q2 2021. 39 funds tracked by Wall St. Rank hold VANI as of Q3 2021.

BBVA USA reported no remaining Vivani Medical position as of Q3 2021 after selling out during the quarter.
BBVA USA sold 1,508 Vivani Medical shares in Q3 2021, an estimated $22K.
BBVA USA first reported a position in Vivani Medical in Q2 2021 and held it in 1 quarter.
BBVA USA's Vivani Medical position peaked at $22K in Q2 2021.
39 funds tracked by Wall St. Rank held Vivani Medical as of Q3 2021.

Based on BBVA USA's 13F filing for Q3 2021, filed 4 Nov 2021.